Estimated Inpatient Visits (Healthcare Cost and Utilization Project, 2018) and Outpatient Visits (National Ambulatory Medical Care Survey/National Hospital Ambulatory Medical Care Survey, 2016–2018 Yearly Average) for Fungal Disease, United States
| Infection . | No. of Inpatient Visits . | Associated Mortality in Inpatient Visits . | No. of Outpatient Visits With Fungal Diagnosis (95% CI) . | ||
|---|---|---|---|---|---|
| Fungi as Primary Cause (95% CI) . | Any Fungal Diagnosis (95% CI) . | Fungi as Primary Cause (% Related Visits) . | Any Fungal Diagnosis (% Related Visits) . | ||
| Aspergillosis | 2480 (2356–2604) | 17 825 (16 934–18 716) | 170 (6.95) | 1870 (10.49) | a |
| Invasive | 1545 (1468–1622) | 8785 (8346–9224) | 120 (7.77) | 1110 (12.64) | a |
| Noninvasive | 460 (437–483) | 4210 (4000–4421) | 15 (3.26) | 155 (3.68) | a |
| Candidiasis | 15 890 (15 096–16 685) | 457 080 (434 226–479 934) | 780 (4.91) | 22 530 (4.93) | 1 973 781 (1 579 024–2 368 536) |
| Invasive | 4880 (4636–5124) | 19 920 (18 924–20 916) | 670 (13.73) | 3380 (16.97) | a |
| Noninvasive | 10 905 (10 360–11 450) | 396 765 (376 927–416 603) | 110 (1.01) | 18 105 (4.56) | 1 437 968 (1 150 374–1 725 561) |
| Coccidioidomycosis | 2265 (2152–2378) | 8990 (8541–9440) | 70 (3.09) | 365 (4.06) | a |
| Cryptococcosis | 1280 (1216–1344) | 4900 (4655–5145) | 90 (7.03) | 455 (9.29) | a |
| Histoplasmosis | 735 (698–772) | 4880 (4636–5124) | 25 (3.40) | 215 (4.41) | 2372 (1660–3083) |
| Mucormycosis | 570 (542–599) | 1370 (1302–1439) | 45 (7.89) | 255 (18.61) | a |
| Pneumocystosis | 1275 (1211–1339) | 9725 (9239–10 211) | 160 (12.55) | 1250 (12.85) | a |
| Other | 2630 (2499–2762) | 145 925 (138 629–153 331) | 95 (3.61) | 3270 (2.24) | 4 429 681 (3 543 744–5 315 617) |
| Unspecified mycoses | 2230 (2119–2342) | 15 540 (14 763–16 317) | a | 2350 (15.12) | 162 412 (129 930–194 894) |
| Total | 29 355 (27 887–30 823) | 666 235 (632 923–699 547) | 1440 (4.91) | 32 560 (4.89) | 6 568 245 (5 254 358–7 882 131) |
| Infection . | No. of Inpatient Visits . | Associated Mortality in Inpatient Visits . | No. of Outpatient Visits With Fungal Diagnosis (95% CI) . | ||
|---|---|---|---|---|---|
| Fungi as Primary Cause (95% CI) . | Any Fungal Diagnosis (95% CI) . | Fungi as Primary Cause (% Related Visits) . | Any Fungal Diagnosis (% Related Visits) . | ||
| Aspergillosis | 2480 (2356–2604) | 17 825 (16 934–18 716) | 170 (6.95) | 1870 (10.49) | a |
| Invasive | 1545 (1468–1622) | 8785 (8346–9224) | 120 (7.77) | 1110 (12.64) | a |
| Noninvasive | 460 (437–483) | 4210 (4000–4421) | 15 (3.26) | 155 (3.68) | a |
| Candidiasis | 15 890 (15 096–16 685) | 457 080 (434 226–479 934) | 780 (4.91) | 22 530 (4.93) | 1 973 781 (1 579 024–2 368 536) |
| Invasive | 4880 (4636–5124) | 19 920 (18 924–20 916) | 670 (13.73) | 3380 (16.97) | a |
| Noninvasive | 10 905 (10 360–11 450) | 396 765 (376 927–416 603) | 110 (1.01) | 18 105 (4.56) | 1 437 968 (1 150 374–1 725 561) |
| Coccidioidomycosis | 2265 (2152–2378) | 8990 (8541–9440) | 70 (3.09) | 365 (4.06) | a |
| Cryptococcosis | 1280 (1216–1344) | 4900 (4655–5145) | 90 (7.03) | 455 (9.29) | a |
| Histoplasmosis | 735 (698–772) | 4880 (4636–5124) | 25 (3.40) | 215 (4.41) | 2372 (1660–3083) |
| Mucormycosis | 570 (542–599) | 1370 (1302–1439) | 45 (7.89) | 255 (18.61) | a |
| Pneumocystosis | 1275 (1211–1339) | 9725 (9239–10 211) | 160 (12.55) | 1250 (12.85) | a |
| Other | 2630 (2499–2762) | 145 925 (138 629–153 331) | 95 (3.61) | 3270 (2.24) | 4 429 681 (3 543 744–5 315 617) |
| Unspecified mycoses | 2230 (2119–2342) | 15 540 (14 763–16 317) | a | 2350 (15.12) | 162 412 (129 930–194 894) |
| Total | 29 355 (27 887–30 823) | 666 235 (632 923–699 547) | 1440 (4.91) | 32 560 (4.89) | 6 568 245 (5 254 358–7 882 131) |
Abbreviation: CI, confidence interval.
Estimates suppressed in keeping with Healthcare Cost and Utilization Project/National Ambulatory Medical Care Survey/National Hospital Ambulatory Medical Care Survey protocols.
Estimated Inpatient Visits (Healthcare Cost and Utilization Project, 2018) and Outpatient Visits (National Ambulatory Medical Care Survey/National Hospital Ambulatory Medical Care Survey, 2016–2018 Yearly Average) for Fungal Disease, United States
| Infection . | No. of Inpatient Visits . | Associated Mortality in Inpatient Visits . | No. of Outpatient Visits With Fungal Diagnosis (95% CI) . | ||
|---|---|---|---|---|---|
| Fungi as Primary Cause (95% CI) . | Any Fungal Diagnosis (95% CI) . | Fungi as Primary Cause (% Related Visits) . | Any Fungal Diagnosis (% Related Visits) . | ||
| Aspergillosis | 2480 (2356–2604) | 17 825 (16 934–18 716) | 170 (6.95) | 1870 (10.49) | a |
| Invasive | 1545 (1468–1622) | 8785 (8346–9224) | 120 (7.77) | 1110 (12.64) | a |
| Noninvasive | 460 (437–483) | 4210 (4000–4421) | 15 (3.26) | 155 (3.68) | a |
| Candidiasis | 15 890 (15 096–16 685) | 457 080 (434 226–479 934) | 780 (4.91) | 22 530 (4.93) | 1 973 781 (1 579 024–2 368 536) |
| Invasive | 4880 (4636–5124) | 19 920 (18 924–20 916) | 670 (13.73) | 3380 (16.97) | a |
| Noninvasive | 10 905 (10 360–11 450) | 396 765 (376 927–416 603) | 110 (1.01) | 18 105 (4.56) | 1 437 968 (1 150 374–1 725 561) |
| Coccidioidomycosis | 2265 (2152–2378) | 8990 (8541–9440) | 70 (3.09) | 365 (4.06) | a |
| Cryptococcosis | 1280 (1216–1344) | 4900 (4655–5145) | 90 (7.03) | 455 (9.29) | a |
| Histoplasmosis | 735 (698–772) | 4880 (4636–5124) | 25 (3.40) | 215 (4.41) | 2372 (1660–3083) |
| Mucormycosis | 570 (542–599) | 1370 (1302–1439) | 45 (7.89) | 255 (18.61) | a |
| Pneumocystosis | 1275 (1211–1339) | 9725 (9239–10 211) | 160 (12.55) | 1250 (12.85) | a |
| Other | 2630 (2499–2762) | 145 925 (138 629–153 331) | 95 (3.61) | 3270 (2.24) | 4 429 681 (3 543 744–5 315 617) |
| Unspecified mycoses | 2230 (2119–2342) | 15 540 (14 763–16 317) | a | 2350 (15.12) | 162 412 (129 930–194 894) |
| Total | 29 355 (27 887–30 823) | 666 235 (632 923–699 547) | 1440 (4.91) | 32 560 (4.89) | 6 568 245 (5 254 358–7 882 131) |
| Infection . | No. of Inpatient Visits . | Associated Mortality in Inpatient Visits . | No. of Outpatient Visits With Fungal Diagnosis (95% CI) . | ||
|---|---|---|---|---|---|
| Fungi as Primary Cause (95% CI) . | Any Fungal Diagnosis (95% CI) . | Fungi as Primary Cause (% Related Visits) . | Any Fungal Diagnosis (% Related Visits) . | ||
| Aspergillosis | 2480 (2356–2604) | 17 825 (16 934–18 716) | 170 (6.95) | 1870 (10.49) | a |
| Invasive | 1545 (1468–1622) | 8785 (8346–9224) | 120 (7.77) | 1110 (12.64) | a |
| Noninvasive | 460 (437–483) | 4210 (4000–4421) | 15 (3.26) | 155 (3.68) | a |
| Candidiasis | 15 890 (15 096–16 685) | 457 080 (434 226–479 934) | 780 (4.91) | 22 530 (4.93) | 1 973 781 (1 579 024–2 368 536) |
| Invasive | 4880 (4636–5124) | 19 920 (18 924–20 916) | 670 (13.73) | 3380 (16.97) | a |
| Noninvasive | 10 905 (10 360–11 450) | 396 765 (376 927–416 603) | 110 (1.01) | 18 105 (4.56) | 1 437 968 (1 150 374–1 725 561) |
| Coccidioidomycosis | 2265 (2152–2378) | 8990 (8541–9440) | 70 (3.09) | 365 (4.06) | a |
| Cryptococcosis | 1280 (1216–1344) | 4900 (4655–5145) | 90 (7.03) | 455 (9.29) | a |
| Histoplasmosis | 735 (698–772) | 4880 (4636–5124) | 25 (3.40) | 215 (4.41) | 2372 (1660–3083) |
| Mucormycosis | 570 (542–599) | 1370 (1302–1439) | 45 (7.89) | 255 (18.61) | a |
| Pneumocystosis | 1275 (1211–1339) | 9725 (9239–10 211) | 160 (12.55) | 1250 (12.85) | a |
| Other | 2630 (2499–2762) | 145 925 (138 629–153 331) | 95 (3.61) | 3270 (2.24) | 4 429 681 (3 543 744–5 315 617) |
| Unspecified mycoses | 2230 (2119–2342) | 15 540 (14 763–16 317) | a | 2350 (15.12) | 162 412 (129 930–194 894) |
| Total | 29 355 (27 887–30 823) | 666 235 (632 923–699 547) | 1440 (4.91) | 32 560 (4.89) | 6 568 245 (5 254 358–7 882 131) |
Abbreviation: CI, confidence interval.
Estimates suppressed in keeping with Healthcare Cost and Utilization Project/National Ambulatory Medical Care Survey/National Hospital Ambulatory Medical Care Survey protocols.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
